Sort
15,440 grants matching “organoids”
SLC9A3 regulation of esophageal dilated intercellular spaces in EoE Subtypes
$624,468Simon Patrick Hogan · University Of Michigan At Ann Arbor · R01 · FY2021 · AI
SLC9A3 regulation of esophageal dilated intercellular spaces in EoE Subtypes
$624,468Simon Patrick Hogan · University Of Michigan At Ann Arbor · R01 · FY2020 · AI
Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell Survival
$624,305Marcus Dasilva Goncalves · New York University School Of Medicine · R01 · FY2025 · CA
Functional and Molecular Characterization of Epithelial Subtypes in Cervical Remodeling and Preterm Birth
$624,219Mala S Mahendroo · Ut Southwestern Medical Center · R01 · FY2024 · HD
Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization
$624,204Wenbo Li · University Of Texas Hlth Sci Ctr Houston · U01 · FY2022 · HL
Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization
$624,204Wenbo Li · University Of Texas Hlth Sci Ctr Houston · U01 · FY2021 · HL
Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization
$624,204Wenbo Li · University Of Texas Hlth Sci Ctr Houston · U01 · FY2023 · HL
Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization
$624,204Wenbo Li · University Of Texas Hlth Sci Ctr Houston · U01 · FY2024 · HL
Roles for uniquely human enhancers in brain development and WNT signaling
$624,109Debra Silver · Duke University · R01 · FY2023 · MH
Natural Products with Selective Cytoxicity to Non Small Cell Lung Cancer
$624,106John D Minna · Ut Southwestern Medical Center · R01 · FY2018 · CA
Function of T cells at the Maternal-Fetal Interface
$624,015Liza Konnikova · Yale University · R01 · FY2025 · AI
Peptoid conjugates targeting prostate cancer
$624,001Michael J Garabedian · New York University School Of Medicine · R01 · FY2024 · CA
Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)
$623,923William Robert Jarnagin · Sloan-Kettering Inst Can Research · U01 · FY2024 · CA
Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance
$623,782Lance L Munn · Massachusetts General Hospital · U01 · FY2025 · CA
Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance
$623,782Lance L Munn · Massachusetts General Hospital · U01 · FY2021 · CA
Radiogenomic Credentialing of Head and Neck Cancer Models
$623,637Mukund Seshadri · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA
Immunotherapy Modeling in Organoids Co-preserving Tumor and Infiltrating Immune Compartments
$623,480Calvin J Kuo · Stanford University · R01 · FY2024 · CA
Esophageal Squamous Cell Cancer Initiation and Immune Landscape Remodeling
$623,452Jae-Il Park · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Advancing immune organoid technology and organoid combinations
$623,357Mark M Davis · Stanford University · U19 · FY2025 · AI
Systemic Enzyme Delivery by a Brain Targeted SapC-DOPS Nanocarrier for Treatment of Neuronopathic Gaucher Disease
$623,281Ying Sun · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · NS
Loss-of-Function Analyses of SETD1A in Human Neural Models
$623,263Zhiping P. Pang · Rutgers Biomedical And Health Sciences · R01 · FY2023 · MH
Mapping the cell specific DNA damage-induced molecular and bioelectrical responses in the 3D cardiac unit
$623,154Tzahi Cohen-Karni · Carnegie-Mellon University · R01 · FY2023 · HL
Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity
$623,084Vinod P Balachandran · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Type III interferon Control of Mucosal Immunity
$622,835Scott B Snapper · Boston Children'S Hospital · R01 · FY2017 · DK
Type III interferon Control of Mucosal Immunity
$622,835Scott B Snapper · Boston Children'S Hospital · R01 · FY2020 · DK